Showing results (101-110 of 259) with videos related to
Sort By:
Pageof 26
Biochemical and Biophysical Research Communications|February 24, 2009
Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cellsDai-lun Chen, Yi-fang Ping, Shi-cang Yu, et al.Frontiers in Oncology|June 5, 2023
Primary pulmonary hyalinizing clear cell carcinoma with fusions of both EWSR1::CREM and IRF2::NTRK3: report of a case with an aggressive behaviorYou-Li Wu, Feng Wu, Mian-Fu Cao, et al.Plos One|October 3, 2012
Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor modelZhi Yang, Qianzhen Zhang, Ke Xu, et al.The American Journal of Pathology|October 13, 2018
miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' PrognosisWenjun Luo, Cuiyun Sun, Junhu Zhou, et al.Plos One|May 15, 2013
Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1Chungang Liu, Limei Liu, Xuejiao Chen, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 2017
Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomasMei Liu, Yong Lin, Xian-Chao Zhang, et al.Cancer Letters|August 18, 2025
Inhibition of CPT1A activates the cGAS/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancerChenglong Li, Tingfang Gao, Qiuling Zhao, et al.ACS Nano|January 9, 2024
An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapyYuhua Cao, Shuaishuai Ding, Yunping Hu, et al.The American Journal of Pathology|September 23, 2023
Tumor Mutation Burden-Related Histopathologic Features for Predicting Overall Survival in Gliomas Using Graph Deep LearningCaixia Sun, Tao Luo, Zhenyu Liu, et al.ACS Nano|May 31, 2023
A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast CancerLijuan Zeng, Shuaishuai Ding, Yuhua Cao, et al.Pageof 26